Rob Hopfner

Rob is a Managing Partner at Pivotal bioVenture Partners LLC, where he focuses on drug discovery and development investments. He has a long track record of working successfully with entrepreneurs to progress novel, important medicines through development and onto the market. Prior to Pivotal, Rob served as a Principal at Bay City Capital LLC. He previously held business development and investment roles at DuPont Pharmaceuticals and Ag-West Biotech LLC. Rob started his career as a pharmacist after completing his post-doctoral work at Harvard Medical School. Rob currently serves as a board member of Vaxcyte, Inc. and Inozyme Pharma, Inc., and on the boards of a number of private life sciences companies.

Rob earned a B.Sc. in pharmacy and a Ph.D. in pharmacology from the University of Saskatchewan and an MBA from the University of Chicago Booth School of Business.